These outcomes, along with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the principle of concentrating on ACKR3 as a singular approach to modulate the opioid program, which could open new therapeutic avenues for opioid-con